The short version of AOD-9604 fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-01-29. Anything still debated is marked as such rather than presented as settled.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
| Property | Value | Notes |
|---|---|---|
| Common name | AOD-9604 | Development code used in scientific literature. |
| Chemical class | Synthetic peptide | Fragment of human growth hormone. |
| Amino acid length | 16 residues | Matches hGH region 176-191. |
| Appearance | White to off-white powder | Typical lyophilized peptide solid. |
| Solubility | Soluble in water | Dissolves in aqueous media; exact behavior depends on salt form. |
Regulatory status: AOD-9604 is not approved as a therapeutic drug in the United States, European Union, or other major markets. It is listed by the World Anti-Doping Agency as a prohibited substance in sport, specifically under growth hormone fragments. Many jurisdictions restrict its sale for human consumption. Products marketed online may not meet pharmaceutical quality standards. The legal status varies by country and often depends on whether the material is presented as a research chemical, supplement, or drug.
Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.
In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
According to biographer Ian Stewart, by the mid-1990s Anwar's leadership ambition was the most serious threat to Mahathir's power. Anwar began to distance himself from Mahathir, overtly promoting his superior religious credentials and suggesting loosening the restrictions on civil liberties. However, Mahathir continued to back Anwar as his successor until the collapse of their relationship during the Asian financial crisis, with Mahathir abandoning the tight monetary and fiscal policies urged by the IMF. As Mahathir took the reins of Malaysia's economic policy over 1998, Anwar was increasingly sidelined. On 2 September, he was dismissed as deputy prime minister and finance minister and promptly expelled from UMNO. No immediate reasons were given for the dismissal. However, the media speculated that it related to lurid allegations of sexual misconduct circulated in a "poison pen letter" at the general assembly. As more allegations surfaced, large public rallies were held in support of Anwar. On 20 September, he was arrested and placed in detention under the Internal Security Act. Anwar stood trial on four charges of corruption, arising from allegations that Anwar abused his power by ordering police to intimidate persons who had alleged Anwar had sodomised them. He was found guilty in April 1999 and sentenced to six years in prison. In another trial shortly after, Anwar was sentenced to another nine years in prison on a conviction for sodomy. The sodomy conviction was overturned on appeal after Mahathir left office.
Forensic DNA analysis takes advantage of the uniqueness of an individual's DNA to answer forensic questions such as paternity/maternity testing and placing a suspect at a crime scene, e.g. in a rape investigation. Forensic engineering is the scientific examination and analysis of structures and products relating to their failure or cause of damage. Forensic entomology deals with the examination of insects in, on and around human remains to assist in determination of time or location of death. It is also possible to determine if the body was moved after death using entomology. Forensic geology deals with trace evidence in the form of soils, minerals and petroleum. Forensic geomorphology is the study of the ground surface to look for potential location(s) of buried object(s). Forensic geophysics is the application of geophysical techniques such as radar for detecting objects hidden underground or underwater. Forensic intelligence process starts with the collection of data and ends with the integration of results within into the analysis of crimes under investigation. Forensic interviews are conducted using the science of professionally using expertise to conduct a variety of investigative interviews with victims, witnesses, suspects or other sources to determine the facts regarding suspicions, allegations or specific incidents in either public or private sector settings. Forensic histopathology is the application of histological techniques and examination to forensic pathology practice.
=== Mechanism of toxicity in humans === After FIAU is converted to FIAU-TP, it is not only available to viral polymerase, in humans it can also be taken up into mitochondria and used by mitochondrial DNA polymerase γ (POLG). When FIAU is incorporated into mitochondrial DNA (mtDNA), it disrupts mtDNA replication, which leads to mtDNA depletion. With less mtDNA, cells can make fewer proteins for the electron transport chain, so oxidative phosphorylation fails. The consequences are lactic acidosis (shift to anaerobic metabolism) and microvascular steatosis (impaired fatty-acid oxidation), especially in the liver
A few incidents have occurred when radioactive material was disposed of improperly, shielding during transport was defective, or when it was simply abandoned or even stolen from a waste store. In the Soviet Union, waste stored in Lake Karachay was blown over the area during a dust storm after the lake had partly dried out. In Italy, several radioactive waste deposits let material flow into river water, thus contaminating water for domestic use. In France in the summer of 2008, numerous incidents happened: in one, at the Areva plant in Tricastin, it was reported that, during a draining operation, liquid containing untreated uranium overflowed out of a faulty tank and about 75 kg of the radioactive material seeped into the ground and, from there, into two rivers nearby; in another case, over 100 staff were contaminated with low doses of radiation. There are ongoing concerns around the deterioration of the nuclear waste site on the Enewetak Atoll of the Marshall Islands and a potential radioactive spill. Scavenging of abandoned radioactive material has been the cause of several other cases of radiation exposure, mostly in developing nations, which may have less regulation of dangerous substances (and sometimes less general education about radioactivity and its hazards) and a market for scavenged goods and scrap metal. The scavengers and those who buy the material are almost always unaware that the material is radioactive and it is selected for its aesthetics or scrap value.
Sources: en.wikipedia.org
The use of fermentation, particularly for beverages, has existed since the Neolithic and has been documented dating from 7000 to 6600 BCE in Jiahu, China, 6000 BCE in Georgia, 3150 BCE in ancient Egypt, 3000 BCE in Babylon, 2000 BCE in pre-Hispanic Mexico, and 1500 BC in Sudan. Fermented foods have a religious significance in Judaism and Christianity. The Baltic god Rugutis was worshiped as the agent of fermentation.
=== Non-tuberculous mycobacteria === Isoniazid may also be used off-label to treat nontuberculous mycobacterial pulmonary disease. Isoniazid was widely used in the treatment of Mycobacterium avium complex as part of a regimen including rifampicin and ethambutol. Evidence suggests that isoniazid prevents mycolic acid synthesis in M. avium complex as in M. tuberculosis and although this is not bactericidal to M. avium complex, it greatly potentiates the effect of rifampicin.
== Sources == The burning of fossil fuels for energy produces 36.8 billion tonnes of CO2 per year as of 2023. Nearly all of this goes into the atmosphere, where approximately half is subsequently absorbed into natural carbon sinks. Less than 1% of CO2 produced annually is put to commercial use.
Sources: en.wikipedia.org
amount of substance Also enplethy, chemical amount, or simply amount. The number of discrete particles (such as molecules, atoms, ions, electrons, or any other atomic-scale entity) in a given sample of matter, divided by the Avogadro constant. The SI unit for amount of substance is the mole (mol).
For services to the Community First Responder Scheme in North Wales. The Reverend Maureen Margaret Wilson. Member, NHS Highland Health and Social Care Chaplaincy Team. For services to Health and Wellbeing. Kenneth Winterbottom. For services to the community in Whittlesford, Cambridgeshire. Roy Wood. Coach, Aspull Wrestling Club, Wigan, Greater Manchester. For services to Wrestling and Young People. Vivienne Wood. For services to the community in the London Borough of Hammersmith and Fulham. Paula Bridget Woolven. For services to the community in East Sussex during Covid-19. Lorna Evelyn Woor. For services to the community in Cambridge. Dr Michael John Worms. For services to the community in Mill Hill, London Borough of Barnet. Louise Wright. Executive Assistant, West Midlands Lieutenancy Office. For services to Local Government and to Charity. Louise Emily Wright. For services to Business and to the community in Hereford. Ronald Wright. Fleet Technical Officer, Northumberland Fire and Rescue Service. For Public Service. Walter Clive Wrigley. For services to St Peter's NHS Healthcare Trust. Pauline Young (Pauline Holden). Lately Watch Manager, Essex County Fire and Rescue Service. For services to the community in Great Baddow, Essex. Sam David Young. For services to the community in Dunfermline.
== Certifications == ASCP offers a number of certifications. International certifications taken outside the United States are denoted as ASCPi. As of 2022, there were 580,000 ASCP and 20,800 ASCPi certificates awarded. In 2023, the number of MLS ASCPi applicants exceeded the number of MLS ASCP applicants. Outside the US, the Philippines is largest ASCPi market with a third of eligible Filipino graduates applying for the MLS (ASCPi) certification annually. The credential is not required for practice in the Philippines, but is appealing for its international work eligibility, primarily immigration to the United States.
Some proteins are synthesized by nonribosomal peptide synthetases, which can be big protein complexes, each specializing in synthesizing only one type of peptide. Nonribosomal peptides often have cyclic or branched structures and can contain non-proteinogenic amino acids – both of these factors differentiate them from ribosome synthesized proteins. An example of nonribosomal peptides are some of the antibiotics.
Sources: en.wikipedia.org
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.
No. It contains only a small portion of the human growth hormone sequence. The full hormone has 191 amino acids and many additional actions that the fragment does not share.
The name refers to the amino acid positions in the human growth hormone chain. The fragment spans residues 176 through 191 at the C-terminal end. This naming convention helps distinguish it from full-length hGH.
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.